Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
13F holders, Q1 2024
Institutional positions in Sunshine Biopharma Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- 0 vs. Q4 2023
- Shares held
- 5.72M
- +2.97M (+108.1%) vs. Q4 2023
- Total value
- $346.2K
- −$399.6K (−53.6%) vs. Q4 2023
- New holders
- 4
- 3 more added
- Sold out
- 4
- 2 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SBFM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $32.6K |
| Q1 2026 | 12 | $127.1K |
| Q4 2025 | 13 | $141.7K |
| Q3 2025 | 14 | $337.3K |
| Q2 2025 | 12 | $187.2K |
| Q1 2025 | 11 | $151.7K |
| Q4 2024 | 12 | $61.8K |
| Q3 2024 | 10 | $111.3K |
| Q2 2024 | 11 | $89.6K |
| Q1 2024 | 15 | $346.2K |
| Q4 2023 | 15 | $745.7K |
| Q3 2023 | 11 | $415.1K |
| Q2 2023 | 10 | $1.25M |
| Q1 2023 | 13 | $292.4K |
| Q4 2022 | 12 | $261.8K |
| Q3 2022 | 12 | $341.1K |
| Q2 2022 | 18 | $802.1K |
| Q1 2022 | 13 | $3.55M |
| Q4 2021 | 1 | $17.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Sunshine Biopharma Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 4,610,900 | $279.0K | 0.00% | +4,544,300+6,823.3% | Added |
| Citadel Advisors LLC | 550,514 | $33.3K | 0.00% | +365,259+197.2% | Added |
| Bridgeway Capital Management, LLC | 286,100 | $17.3K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 87,610 | $5.30K | 0.00% | +87,610 | New |
| Royal Bank of Canada | 65,000 | $4.00K | 0.00% | +65,000 | New |
| XTX Topco Ltd | 53,722 | $3.25K | 0.00% | +36,227+207.1% | Added |
| Geode Capital Management, LLC | 20,179 | $1.22K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 19,196 | $1.16K | 0.00% | +19,196 | New |
| HRT Financial LP | 18,068 | $1.00K | 0.00% | +18,068 | New |
| Bank of America Corp | 10,000 | $600 | 0.00% | 00.0% | Unchanged |
| Main Street Group, LTD | 222 | $24 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 79 | $5 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 68 | $4 | 0.00% | −745−91.6% | Reduced |
| Rise Advisors, LLC | 18 | $1 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1 | $0 | 0.00% | −2,200−100.0% | Reduced |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −2,130,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −23,862−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −6,042−100.0% | Sold out |
| Oliver Lagore Vanvalin Investment Group | 0 | $0 | 0.00% | −1−100.0% | Sold out |